From: Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis
Time point (months)
OsteoAMPĀ® with BMA (%) (nā=ā132)
OsteoAMPĀ® without BMA (%) (nā=ā94)
3
18.9
18.1
6
61.9
56.7
12
94.7
92.6
18
99.1
98.7